Live from the NIH registry
Studies recruiting near Birmingham right now
Top 25 of 966 recruiting studies, sorted by proximity — each links to its official registry page
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Amyotrophic Lateral Sclerosis
Phase 3
Interventional 495 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: AB Science
Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
Non-hodgkin Lymphoma, Hodgkin Lymphoma
Phase 2
Interventional 80 participants sought
University of Alabama — Birmingham, Alabama (0.6 mi)
· Sponsor: New York Medical College
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of Alabama — Birmingham, Alabama (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
Radiation Free Study
Aortic Aneurysm
N/A
Interventional 182 participants sought
University of Alabama — Birmingham, Alabama (0.6 mi)
· Sponsor: Philips Clinical & Medical Affairs Global
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Flourish - Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: AbbVie
Process-Based Approach Case Series For Anxiety Problems
Anxiety
N/A
Interventional 10 participants sought
University of Alabama at Birmingham Dr. Borgogna's lab — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Veterans Administration Medical Center - Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: SWOG Cancer Research Network
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Bendcare, LLC — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
International Weight Control Registry
Weight Loss, Overweight
N/A
Observational 100,000 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Tufts University
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 1, Phase 2
Interventional 260 participants sought
UAB Comprehensive Cancer Center — Birmingham, Alabama (0.6 mi)
· Sponsor: Bristol-Myers Squibb
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Annovis Bio Inc.
Diet Interventions: Remitted and Evaluated as Complementary Treatments for Pain
Knee Osteoarthritis
N/A
Interventional 200 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Birmingham, Alabama (0.6 mi)
· Sponsor: AstraZeneca
Wavelength Intervention for Nearsighted Kids
Myopia
N/A
Interventional 80 participants sought
University of Alabama at Birmingham School of Optometry — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Jaeb Center for Health Research
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Birmingham, Alabama (0.6 mi)
· Sponsor: Sameek Roychowdhury
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction
Phase 3
Interventional 2,000 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Uppsala University
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Myelodysplastic Syndrome, Acute Myeloid Leukemia
Phase 1
Interventional 178 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
University of Alabama/Children's of Alabama — Birmingham, Alabama (0.6 mi)
· Sponsor: Giselle Sholler
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
Systemic Lupus Erythematosus of Childhood (Disorder)
N/A
Interventional 175 participants sought
University of Alabama Birmingham Hospital — Birmingham, Alabama (0.6 mi)
· Sponsor: Michigan State University
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Birmingham, Alabama (0.6 mi)
· Sponsor: AstraZeneca
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
MTAP-deleted Solid Tumors
Phase 1, Phase 2
Interventional 450 participants sought
UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital — Birmingham, Alabama (0.6 mi)
· Sponsor: Bayer
Investigating Inhibitory Control Networks in Parkinson's Disease
Parkinson Disease
N/A
Interventional 140 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Guardant Health, Inc.
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
IgA Nephropathy
Phase 4
Interventional 60 participants sought
Univ of Alabama/Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Calliditas Therapeutics AB